RE:RE:RE:RE:Leah GibsonLevesque should realize how important how they handle the IR function is to his legacy at THTX. As you rightly point out, he did not hire Leah but he now has an opportunity to get someone who matches his needs best and hopefully generates results with the stock price that will make Paul look good. And given Paul's lack of experience in the financial arena, he needs to find someone who has the financial market's experience he lacks.
THTX has had a long history of not getting decent analyst coverage. Part of that has been their home country bias so they really do need to break free of that as Canadian analysts have not been the answer. We have seen THTX break free of that by appointing non-Canadian board members and on the marketing side of the equation and they tried to go outside Canada with Leah. Hopefully, they know they have some very interesting cancer data already and know they both need to, and will have the resources, to step up and hire someone a bit more senior than Leah this time around. When they hired her, it made sense to take a flyer on a junior person and hope she blossomed intno a great senior IR asset. But now, they should be targetting a more senior and already accomplished IR officer, assuming they are confident in their cancer program. They might not be able to hire anyone very senior until that data is out as a senior IR person would not likely join THTX unless they already knew the future was very bright.
Wino115 wrote: Congrats to her, glad it worked out and hopefully the IR situation will work out for THTX. While smaller, they average over a million shares a day which means there's at least an active audience. THTX needs that kind of average volume!
May not be easy to work there for the uppity ups if you're the IR person. There's a few layers of managment you need to get through. It may actually be a far better situation if PL gets to be part of this IR hire and there's maybe a dotted line report if it's a senior enough person and PL realizes the importance of the person and role for his future and THTX's future.
SPCEO1 wrote: I took a quick look at CYBN. There are already eight analysts covering this Toronto headquartered company which is seeking to make approved drugs from the key element in magic mushrooms. The amrkeet cap is virtually the same as THTX and the share price is even lower. So, Leah will not have the problem of too few analysts covering the stock (psychedelic stocks have been hot commodities from time to time recently) but still will need to contend with a small market cap and share price. Retail investors are going to be the most fertile ground for her in this new position, especially given the nature of the business and that cetainly was not a skill set she developed at THTX. But I wish her the best in her new job.
To me, this move is, at best, a lateral move for her. Let;s hope it is something that works out well for both her and for THTX.
jfm1330 wrote: So, she is good enough to be V-P at Cybin, it seems they think she is good.
jfm1330 wrote: She is now V-P IR at Cybin. So I would guess she left Thera, she was not fired.